z-logo
open-access-imgOpen Access
Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
Author(s) -
Atsuko Hata,
Hideomi Asanuma,
Mary Rinki,
Margaret Sharp,
Ruby M. Wong,
Karl G. Blume,
Ann M. Arvin
Publication year - 2002
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa013441
Subject(s) - medicine , varicella zoster virus , transplantation , varicella vaccine , hematopoietic cell , hematopoietic stem cell transplantation , virus , lymphoma , immunology , surgery , gastroenterology , haematopoiesis , immunization , immune system , stem cell , biology , genetics
The reactivation of varicella-zoster virus from latency causes zoster and is common among recipients of hematopoietic-cell transplants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom